Biotech · Private company
Keryx Biopharmaceuticals
Track this companyFree. Adds Keryx Biopharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ferric citratePhase 3 · Hyperphosphatemia Related to Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- KRX-0502Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- SulodexideDiabetic NephropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseasePHASE3 · SUSPENDED · started Jun 16, 2022ClinicalTrials.gov NCT04523727 · fetched Nov 12, 2026
- KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)PHASE4 · COMPLETED · started Aug 15, 2017ClinicalTrials.gov NCT03236246 · fetched Nov 12, 2026
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis PatientsPHASE4 · COMPLETED · started May 1, 2017ClinicalTrials.gov NCT03079869 · fetched Nov 12, 2026
- A Study of Ferric Citrate to Improve Inflammation and Lipid LevelsPHASE4 · TERMINATED · started Jul 1, 2015ClinicalTrials.gov NCT02661295 · fetched Nov 12, 2026
- Effect of Sulodexide in Overt Diabetic NephropathyPHASE4 · TERMINATED · started Aug 1, 2005ClinicalTrials.gov NCT00130312 · fetched Nov 12, 2026